Lucid Diagnostics
LUCD • NASDAQ
Lucid Diagnostics is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Lishan Aklog, with a market cap of $190.8M.
CEOLishan Aklog
Next Earnings
Upcoming earnings announcement for Lucid Diagnostics
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.07
Revenue Estimate
$1.4M
Earnings History
Past 12 earnings reports for Lucid Diagnostics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.10Est: -$0.08 | -25.0% | $1.5MEst: $1.3M | +12.6% | — |
| Nov 12, 2025 | Q3 2025 | -$0.10Est: -$0.08 | -25.0% | $1.2MEst: $1.3M | -9.1% |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.10Est: -$0.10 | 0.0% | $1.2MEst: $1.0M | +11.1% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.16Est: -$0.10 | -60.0% | $800.0KEst: $1.5M | -48.1% | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$0.19Est: -$0.15 | -26.7% | $1.2MEst: $1.4M | -15.7% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.20Est: -$0.22 | +9.1% | $1.2MEst: $1.1M | +2.8% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.20Est: -$0.22 | +9.1% | $976.0KEst: $1.2M | -20.7% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.21Est: -$0.27 | +22.2% | $1.0MEst: $1.1M | -4.7% | 10-Q |
| Mar 25, 2024 | Q4 2023 | -$0.23Est: -$0.26 | +11.5% | $1.0MEst: $1.1M | -1.0% | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.22Est: -$0.27 | +18.5% | $783.0KEst: $780.0K | +0.4% | — |
| Aug 14, 2023 | Q2 2023 | -$0.23Est: -$0.32 | +28.1% | $159.0KEst: $620.0K | -74.4% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.24Est: -$0.35 | +31.4% | $446.0KEst: $220.0K | +102.7% | 10-Q |